595-nm Pulsed Dye Laser for the Treatment of Facial Lentigines
Keywords:
595-nm pulsed dye laser, photorejuvenation, photodamage, lentiginesAbstract
595-nm PDL is one of the popular non-ablative lasers for facial rejuvenation. Recent addition of compression handpiece (CHP) allows treatments with minimal adverse effects.The purpose of this study was to evaluate the efficacy of 595-nm PDL in the treatment of facial lentigines. 10 subjects were enrolled in this study. One side of the face was treated with one pass of 595-nm PDL 6 J/cm2, 6 ms. Then, lentigines were individually treated with CHP. The untreated side served as control. Photographs were taken and the number of lentigines was analyzed by VISIA®. All subjects were female aged from 39 to 55 years with moderate photodamaged skin. There was improvement of lentigines by global assessment at 3rd month (p = 0.008). The mean change in number of lentigines on the treated side was -6.1, while that of the controlled side was +2.8 (p = 0.075). Hyperpigmentation was found in 2 subjects.
References
Gilchrest BA. Skin aging and photoaging: An overview. J Am Acad Dermatol 1989; 21: 610-613.
Rabe JH, Mamelak AJ, McElgunn P, Morison WL, Sauder DN. Photoaging: Mechanisms and repair. J Am Acad Dermatol 2006; 55: 1-19.
Taylor CR, Anderson RR. Treatment of benign pigmented epidermal lesions by Q- switched ruby laser. Int J Dermatol 1993; 32: 908-12.
Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and café-au-lait macules with Q-switched ruby laser. Aesthetic Plast Surg 1997; 21: 445-8.
Chan HH, Fung WK, Ying S, Kono T. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in Oriental patients. Dermatol Surg 2000; 26: 743-9.
Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. Arch Dermatol 1994; 130: 1515-9.
Rashid T, Hussain I, Haider M, Haroon TS. Laser therapy of freckles and lentigines with quasi-continuous, frequency-doubled, Nd:YAG (532 nm) laser in Fitzpatrick skin type IV: a 24-month follow up. J Cosmetic & Laser Ther 2002; 4: 81-5.
Rosenbach A, Lee SJ, Johr RH. Treament of medium-brown solar lentigines using an alexandrite laser designed for hair reduction. Arch Dermatol 2002; 138: 547-8.
Wang C, Sue Y, Yang C, Chen C. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: A randomized, physician-blinded, split-face comparative trial. J Am Acad Dermatol 2006; 54: 804-10.
Tanghetti E, Sherr EA, Alvarado SL. Multipass treatment of photodamage using the pulsed dye laser. Dermatol Surg 2003; 29: 686-91.
Kono T, Manstein D, Chan HH, Nozaki M, Anderson RR. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med 2006; 38: 94-7.
Kauvar AN, Rosen N, Khrom T. A newly modified 595-nm pulsed dye laser with compression handpiece for the treatment of photodamaged skin. Lasers Surg Med 2006; 38: 808-13.
Kono T, Chan HH, Groff WF, Sakurai H, Takeuchi M, Yamaki T et al. Long-pulse pulsed dye laser delivered with compression for treatment of facial lentigines. Dermatol Surg 2007; 33: 945-950.
Bernstein EF. The new-generation, high-energy, 595-nm, long pulse-duration pulsed-dye laser improves the appearance of photodamaged skin. Lasers Surg Med 2007; 39: 157-63.
Kono T, Groff WF, Sakurai H, Takeuchi M, Yamaki T, Soejima K et al. Comparison study of intense pulsed light versus a long-pulse pulsed dye laser in the treatment of facial skin rejuvenation. Ann of Plast Surg 2007; 59: 479-483.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2008 Thai Journal of Dermatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น
